Devices › Device types
FDA product code LMG · class 3 · General, Plastic Surgery
Agent, absorbable hemostatic, non-collagen based: medical device reports filed with FDA
1,764 reports carry this product code, 1996–2026; 5 brands with a page.
- 1,764
- reports with this product code
- 0% of all MAUDE reports
- 228
- reports, 12 months to August 2026
- 239 in the 12 months before
- 23%
- classified as malfunction
- 62.3% across all reports
- 1.5%
- classified as death, as reported
- 0.9% across all reports
Product code LMG is FDA's classification for "Agent, absorbable hemostatic, non-collagen based" (general, Plastic Surgery panel), a class 3 device. 1,764 medical device reports carry this product code, 0% of the MAUDE database, from October 1996 to August 2026.
228 reports arrived in the 12 months to August 2026, close to the 239 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (74.9%), malfunction (23%) and death (1.5%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Surgicel Absorbable Hemostat Unknown | 296 | 26 | 3.3% | 3% |
| Surgicel Powder Usa - Absorbable Hemostatic Pwdr | 293 | 0 | 0.3% | 2.7% |
| Surgicel Absorbable Hemostat | 122 | 0 | 2.1% | 0.7% |
| Ethicon | 1 | 164 | 2.3% | 54.2% |
| Floseal | 1 | 7 | 3.7% | 35.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Ethicon | 307 | 17.4% |
| Davol Sub C R Bard -1213643 | 89 | 5% |
| Covidien North Haven | 51 | 2.9% |
| Davol Sub C R Bard | 44 | 2.5% |
| Covidien Surgical | 4 | 0.2% |
| Cryolife | 3 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Device markings/labelling problema problem with the device markings or label | 100 | 5.7% |
| Delivered as unsterile product | 91 | 5.2% |
| Patient-device incompatibilitythe device did not suit the patient | 73 | 4.1% |
| Device contaminated during manufacture or shipping | 70 | 4% |
| Reactiona reaction, type not specified | 68 | 3.9% |
| Other (for use when an appropriate device code cannot be identified) | 41 | 2.3% |
| Insufficient device problem information | 28 | 1.6% |
| Material integrity problema problem with the device material | 28 | 1.6% |
| Patient device interaction problem | 28 | 1.6% |
| Breakthe device broke | 18 | 1% |
| Degraded | 13 | 0.7% |
| Product quality problem | 11 | 0.6% |
| Component missing | 10 | 0.6% |
| Packaging problem | 10 | 0.6% |
| Explanted | 9 | 0.5% |
| Migration or expulsion of device | 7 | 0.4% |
| Detachment of device or device componentpart of the device came off | 6 | 0.3% |
| Device contamination with chemical or other material | 6 | 0.3% |
| Device remains implanted | 6 | 0.3% |
| Loss of or failure to bond | 6 | 0.3% |
Questions about agent, absorbable hemostatic, non-collagen based reports
What is product code LMG?
FDA's classification code for "Agent, absorbable hemostatic, non-collagen based", class 3, reviewed by the general, Plastic Surgery panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,764 reports through August 2026, 228 of them in the latest 12 months.
Which brands appear most often?
Surgicel Absorbable Hemostat Unknown (296), Surgicel Powder Usa - Absorbable Hemostatic Pwdr (293), Surgicel Absorbable Hemostat (122), Ethicon (1) and Floseal (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.